Archford Capital Strategies’s Goldman Sachs Human Evolution ETF GDNA Stock Holding History

Archford Capital Strategies’s Portfolio GDNA Stock Details GDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-164	Closed	-$9K	–	557
2019 Q2	$9K	Buy	+164	New	+$8.08K	﹤0.01%	417

Other funds holding GDNA

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 57.61% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

SFS

Sowell Financial Services North Little Rock, Arkansas $3.06B AUM 30.02% 1-Year Est. Return

Archford Capital Strategies's GDNA Position: Q3 2019 in Review

Archford Capital Strategies sold out of Goldman Sachs Human Evolution ETF (GDNA) in Q3 2019, closing a stake of 164 shares — an estimated $9K sold.

Archford Capital Strategies first reported a position in GDNA in Q2 2019 and held it in 1 quarter. The position peaked at $9K in Q2 2019. 6 funds tracked by Wall St. Rank hold GDNA as of Q3 2019.

Archford Capital Strategies reported no remaining Goldman Sachs Human Evolution ETF position as of Q3 2019 after selling out during the quarter.
Archford Capital Strategies sold 164 Goldman Sachs Human Evolution ETF shares in Q3 2019, an estimated $9K.
Archford Capital Strategies first reported a position in Goldman Sachs Human Evolution ETF in Q2 2019 and held it in 1 quarter.
Archford Capital Strategies's Goldman Sachs Human Evolution ETF position peaked at $9K in Q2 2019.
6 funds tracked by Wall St. Rank held Goldman Sachs Human Evolution ETF as of Q3 2019.

Based on Archford Capital Strategies's 13F filing for Q3 2019, filed 23 Oct 2019.